GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...

A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why - There’s no direct link ...

A new form of energy-efficient artificial vision system inspired by the human brain and made in part using honey could help ...